APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Receptor Tyrosine Protein Kinase TYK2

Compare research editions
View pricing & licenses

Selected research

Industry Research

Non Receptor Tyrosine Protein Kinase TYK2 Industry Research Report 2026

19 December 2025117 pages

Choose your research edition.

Industry ResearchNon Receptor Tyrosine Protein Kinase TYK2 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Receptor Tyrosine Protein Kinase TYK2 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non Receptor Tyrosine Protein Kinase TYK2 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Non Receptor Tyrosine Protein Kinase TYK2 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Non Receptor Tyrosine Protein Kinase TYK2 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Non Receptor Tyrosine Protein Kinase TYK2 include Takeda Pharmaceutical Company Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Theravance Biopharma Inc, Sareum Holdings Plc, Portola Pharmaceuticals Inc, Nimbus Therapeutics LLC and Array BioPharma Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Non Receptor Tyrosine Protein Kinase TYK2 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Non Receptor Tyrosine Protein Kinase TYK2 Market by Company

Takeda Pharmaceutical Company Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Theravance Biopharma Inc

Sareum Holdings Plc

Portola Pharmaceuticals Inc

Nimbus Therapeutics LLC

Array BioPharma Inc

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Type

ARRY-624

BMS-986165

NDI-031232

Cerdulatinib

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Application

Follicular Lymphoma

Lupus Nephritis

Hypersensitivity

Marginal Zone B-cell Lymphoma

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Receptor Tyrosine Protein Kinase TYK2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Receptor Tyrosine Protein Kinase TYK2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Receptor Tyrosine Protein Kinase TYK2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Non Receptor Tyrosine Protein Kinase TYK2 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Non Receptor Tyrosine Protein Kinase TYK2 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Non Receptor Tyrosine Protein Kinase TYK2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Non Receptor Tyrosine Protein Kinase TYK2 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Manufacturers (2021-2026) Table 8. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue of Manufacturers (2021-2026) Table 9. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Non Receptor Tyrosine Protein Kinase TYK2 Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Non Receptor Tyrosine Protein Kinase TYK2 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Non Receptor Tyrosine Protein Kinase TYK2, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Non Receptor Tyrosine Protein Kinase TYK2, Product Type & Application Table 14. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Non Receptor Tyrosine Protein Kinase TYK2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Pharmaceutical Company Ltd Company Information Table 19. Takeda Pharmaceutical Company Ltd Business Overview Table 20. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 22. Takeda Pharmaceutical Company Ltd Recent Developments Table 23. Pfizer Inc Company Information Table 24. Pfizer Inc Business Overview Table 25. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 27. Pfizer Inc Recent Developments Table 28. Bristol-Myers Squibb Company Company Information Table 29. Bristol-Myers Squibb Company Business Overview Table 30. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 32. Bristol-Myers Squibb Company Recent Developments Table 33. Theravance Biopharma Inc Company Information Table 34. Theravance Biopharma Inc Business Overview Table 35. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 37. Theravance Biopharma Inc Recent Developments Table 38. Sareum Holdings Plc Company Information Table 39. Sareum Holdings Plc Business Overview Table 40. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 42. Sareum Holdings Plc Recent Developments Table 43. Portola Pharmaceuticals Inc Company Information Table 44. Portola Pharmaceuticals Inc Business Overview Table 45. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 47. Portola Pharmaceuticals Inc Recent Developments Table 48. Nimbus Therapeutics LLC Company Information Table 49. Nimbus Therapeutics LLC Business Overview Table 50. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 52. Nimbus Therapeutics LLC Recent Developments Table 53. Array BioPharma Inc Company Information Table 54. Array BioPharma Inc Business Overview Table 55. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 57. Array BioPharma Inc Recent Developments Table 58. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2026) & (K Units) Table 60. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2021-2026) Table 61. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2027-2032) & (K Units) Table 62. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2027-2032) Table 63. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2021-2026) Table 65. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2027-2032) Table 67. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 69. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 70. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 74. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 75. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 79. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 80. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 84. South America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 85. South America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 89. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 90. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 93. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 94. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2026) Table 95. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2027-2032) Table 96. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2026) Table 99. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2027-2032) Table 100. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2026) & (US$/Unit) Table 101. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2027-2032) & (US$/Unit) Table 102. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 103. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 104. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2026) Table 105. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2027-2032) Table 106. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2026) Table 109. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2027-2032) Table 110. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2026) & (US$/Unit) Table 111. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Non Receptor Tyrosine Protein Kinase TYK2 Distributors List Table 115. Non Receptor Tyrosine Protein Kinase TYK2 Customers List Table 116. Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends Table 117. Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers Table 118. Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Non Receptor Tyrosine Protein Kinase TYK2 Product Image Figure 5. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size (2021-2032) & (US$ Million) Figure 7. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (2021-2032) & (K Units) Figure 8. Global Non Receptor Tyrosine Protein Kinase TYK2 Average Price (US$/Unit) & (2021-2032) Figure 9. ARRY-624 Product Image Figure 10. BMS-986165 Product Image Figure 11. NDI-031232 Product Image Figure 12. Cerdulatinib Product Image Figure 13. Others Product Image Figure 14. Follicular Lymphoma Product Image Figure 15. Lupus Nephritis Product Image Figure 16. Hypersensitivity Product Image Figure 17. Marginal Zone B-cell Lymphoma Product Image Figure 18. Others Product Image Figure 19. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Non Receptor Tyrosine Protein Kinase TYK2, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Non Receptor Tyrosine Protein Kinase TYK2 Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region in 2025 Figure 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region in 2025 Figure 26. North America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country in 2025 Figure 27. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 28. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2021-2032) Figure 29. United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country in 2025 Figure 32. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 33. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2021-2032) Figure 34. Germany Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country in 2025 Figure 40. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2021-2032) Figure 42. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country in 2025 Figure 51. South America Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 52. South America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2021-2032) Figure 53. Mexico Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country in 2025 Figure 57. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2021-2032) Figure 59. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2032) Figure 63. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2032) Figure 64. Global Non Receptor Tyrosine Protein Kinase TYK2 Price (US$/Unit) by Type (2021-2032) Figure 65. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2032) Figure 66. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2032) Figure 67. Global Non Receptor Tyrosine Protein Kinase TYK2 Price (US$/Unit) by Application (2021-2032) Figure 68. Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Figure 69. Non Receptor Tyrosine Protein Kinase TYK2 Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges

Scope & coverage.

Types
  • ARRY-624
  • BMS-986165
  • NDI-031232
  • Cerdulatinib
  • Others
Applications
  • Follicular Lymphoma
  • Lupus Nephritis
  • Hypersensitivity
  • Marginal Zone B-cell Lymphoma
  • Others
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Theravance Biopharma Inc
  • Sareum Holdings Plc
  • Portola Pharmaceuticals Inc
  • Nimbus Therapeutics LLC
  • Array BioPharma Inc

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size (2021-2032)
  4. 2.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (2021-2032)
  5. 2.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Average Price (2021-2032)
  6. 2.3 Non Receptor Tyrosine Protein Kinase TYK2 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 ARRY-624
  9. 2.3.3 BMS-986165
  10. 2.3.4 NDI-031232
  11. 2.3.5 Cerdulatinib
  12. 2.3.6 Others
  13. 2.4 Non Receptor Tyrosine Protein Kinase TYK2 by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Follicular Lymphoma
  16. 2.4.3 Lupus Nephritis
  17. 2.4.4 Hypersensitivity
  18. 2.4.5 Marginal Zone B-cell Lymphoma
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Non Receptor Tyrosine Protein Kinase TYK2 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Non Receptor Tyrosine Protein Kinase TYK2, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Non Receptor Tyrosine Protein Kinase TYK2, Product Type & Application
  8. 3.8 Global Manufacturers of Non Receptor Tyrosine Protein Kinase TYK2, Established Date
  9. 3.9 Global Non Receptor Tyrosine Protein Kinase TYK2 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda Pharmaceutical Company Ltd
  2. 4.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 4.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 4.1.3 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  6. 4.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 4.2 Pfizer Inc
  8. 4.2.1 Pfizer Inc Company Information
  9. 4.2.2 Pfizer Inc Business Overview
  10. 4.2.3 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  12. 4.2.5 Pfizer Inc Recent Developments
  13. 4.3 Bristol-Myers Squibb Company
  14. 4.3.1 Bristol-Myers Squibb Company Company Information
  15. 4.3.2 Bristol-Myers Squibb Company Business Overview
  16. 4.3.3 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  18. 4.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 4.4 Theravance Biopharma Inc
  20. 4.4.1 Theravance Biopharma Inc Company Information
  21. 4.4.2 Theravance Biopharma Inc Business Overview
  22. 4.4.3 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  24. 4.4.5 Theravance Biopharma Inc Recent Developments
  25. 4.5 Sareum Holdings Plc
  26. 4.5.1 Sareum Holdings Plc Company Information
  27. 4.5.2 Sareum Holdings Plc Business Overview
  28. 4.5.3 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  30. 4.5.5 Sareum Holdings Plc Recent Developments
  31. 4.6 Portola Pharmaceuticals Inc
  32. 4.6.1 Portola Pharmaceuticals Inc Company Information
  33. 4.6.2 Portola Pharmaceuticals Inc Business Overview
  34. 4.6.3 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  36. 4.6.5 Portola Pharmaceuticals Inc Recent Developments
  37. 4.7 Nimbus Therapeutics LLC
  38. 4.7.1 Nimbus Therapeutics LLC Company Information
  39. 4.7.2 Nimbus Therapeutics LLC Business Overview
  40. 4.7.3 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  42. 4.7.5 Nimbus Therapeutics LLC Recent Developments
  43. 4.8 Array BioPharma Inc
  44. 4.8.1 Array BioPharma Inc Company Information
  45. 4.8.2 Array BioPharma Inc Business Overview
  46. 4.8.3 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  48. 4.8.5 Array BioPharma Inc Recent Developments
5 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Scenario by Region
  1. 5.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021-2032
  3. 5.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021-2026
  4. 5.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2027-2032
  5. 5.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region: 2021-2032
  6. 5.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region: 2021-2026
  7. 5.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region: 2027-2032
  8. 5.4 North America Non Receptor Tyrosine Protein Kinase TYK2 Market Facts & Figures by Country
  9. 5.4.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  11. 5.4.3 North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Non Receptor Tyrosine Protein Kinase TYK2 Market Facts & Figures by Country
  15. 5.5.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  17. 5.5.3 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Non Receptor Tyrosine Protein Kinase TYK2 Market Facts & Figures by Country
  35. 5.7.1 South America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  37. 5.7.3 South America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  2. 6.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2032)
  4. 6.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  5. 6.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  2. 7.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2032)
  4. 7.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  5. 7.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Analysis
  2. 8.1.1 Non Receptor Tyrosine Protein Kinase TYK2 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Non Receptor Tyrosine Protein Kinase TYK2 Production Mode & Process
  5. 8.2 Non Receptor Tyrosine Protein Kinase TYK2 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Distributors
  8. 8.2.3 Non Receptor Tyrosine Protein Kinase TYK2 Customers
9 Global Non Receptor Tyrosine Protein Kinase TYK2 Analyzing Market Dynamics
  1. 9.1 Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends
  2. 9.2 Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers
  3. 9.3 Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges
  4. 9.4 Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst